Tango Therapeutics Inc (TNGX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Tango Therapeutics* Bold Move: Stock Options Unleashed to Fuel Cancer Precision Revolution
Tango Therapeutics Inc. Reports Stunning Loss of $-0.23 per Share, Shakes Market Confidence
TNGX in the financial time-frame ending December 31 2022
Shortfall Regardless of Revenues improvement at in the most recent fiscal period